IRWD Ironwood Pharmaceuticals, Inc. Stock Quote

IRWD [NASD]

Healthcare | Drug Manufacturers - Specialty & Generic | USA

Index	-	P/E	15.62	EPS (ttm)	0.66	Insider Own	1.70%	Shs Outstand	160.07M	Perf Week	-3.64%
Market Cap	1.68B	Forward P/E	9.86	EPS next Y	1.05	Insider Trans	439.05%	Shs Float	155.36M	Perf Month	-8.88%
Income	106.20M	PEG	-	EPS next Q	0.20	Inst Own	-	Short Float	13.20%	Perf Quarter	-11.35%
Sales	389.50M	P/S	4.32	EPS this Y	74.90%	Inst Trans	-0.50%	Short Ratio	8.93	Perf Half Y	-1.72%
Book/sh	0.39	P/B	26.44	EPS next Y	8.96%	ROA	22.40%	Target Price	11.00	Perf Year	4.78%
Cash/sh	2.22	P/C	4.64	EPS next 5Y	-	ROE	-	52W Range	8.63 - 12.55	Perf YTD	-9.48%
Dividend	-	P/FCF	10.08	EPS past 5Y	21.60%	ROI	28.50%	52W High	-15.70%	Beta	1.38
Dividend %	-	Quick Ratio	-	Sales past 5Y	21.10%	Gross Margin	99.20%	52W Low	22.60%	ATR	0.40
Employees	232	Current Ratio	15.40	Sales Q/Q	-7.60%	Oper. Margin	36.70%	RSI (14)	49.35	Volatility	3.07% 3.49%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	-12.50%	Profit Margin	27.30%	Rel Volume	0.42	Prev Close	10.31
Shortable	Yes	LT Debt/Eq	6.87	Earnings	Feb 17 BMO	Payout	0.00%	Avg Volume	2.30M	Price	10.58
Recom	2.60	SMA20	-2.53%	SMA50	1.78%	SMA200	0.99%	Volume	475,948	Change	2.62%

Sep-30-20

Downgrade

Wells Fargo

Overweight → Equal Weight

$14 → $9

Jun-17-20

Initiated

Northland Capital

Outperform

$14

Jul-10-19

Resumed

Credit Suisse

Neutral

Mar-27-19

Upgrade

Morgan Stanley

Underweight → Equal-Weight

Feb-25-19

Upgrade

H.C. Wainwright

Sell → Neutral

$14

Jan-24-19

Upgrade

JP Morgan

Underweight → Neutral

Nov-07-18

Downgrade

JP Morgan

Neutral → Underweight

Nov-07-18

Downgrade

Credit Suisse

Outperform → Neutral

Jul-23-18

Initiated

H.C. Wainwright

Sell

$12.50

May-09-18

Downgrade

Morgan Stanley

Equal-Weight → Underweight

Jan-05-18

Downgrade

BofA/Merrill

Buy → Underperform

Dec-06-17

Downgrade

Mizuho

Buy → Neutral

$16

Jul-21-17

Downgrade

JP Morgan

Overweight → Neutral

May-03-17

Initiated

Wells Fargo

Outperform

Apr-07-17

Reiterated

Mizuho

Buy

$21 → $22

Feb-22-17

Reiterated

Barclays

Equal Weight

$13 → $16

Nov-04-16

Reiterated

Mizuho

Buy

$19 → $20

Oct-24-16

Reiterated

Wedbush

Neutral

$10 → $13

Oct-10-16

Reiterated

Mizuho

Buy

$24 → $19

Sep-27-16

Reiterated

WallachBeth

Hold

$15 → $17

Mar-19-21 11:30AM	Ironwood (IRWD) Up 20.4% Since Last Earnings Report: Can It Continue? Zacks
Mar-01-21 06:40AM	Edward Owens Is The Independent Director of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) And They Just Picked Up 5.9% More Shares Simply Wall St.
Feb-27-21 06:15AM	3 Undervalued Biotechs Worth Adding to Your Watch List Motley Fool
Feb-19-21 04:01PM	Ironwood Pharmaceuticals to Present at Upcoming Investor Conferences Business Wire
Feb-17-21 12:00PM	Ironwood Pharmaceuticals Inc (IRWD) Q4 2020 Earnings Call Transcript Motley Fool
07:48AM	Recap: Ironwood Pharmaceuticals Q4 Earnings Benzinga
07:01AM	Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Results, Exceeding or Meeting Full Year 2020 Financial Guidance; Provides Full Year 2021 Financial Guidance Business Wire
06:30AM	Ironwood Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
Feb-10-21 12:31PM	Earnings Preview: Ironwood Pharmaceuticals (IRWD) Q4 Earnings Expected to Decline Zacks
Feb-09-21 08:09AM	The Daily Biotech Pulse: Dynavax Poaches GSK Vaccine Exec, KalVista Jumps On Data Readout, Corcept Issues Negative Preannouncement Benzinga
04:58AM	Ironwood CEO Steps Down Months After Clinical Trial Failure, Names Thomas McCourt As Interim Chief Executive Benzinga
Feb-08-21 04:01PM	Ironwood Pharmaceuticals Announces CEO Transition Business Wire
03:18AM	Investors Aren't Entirely Convinced About Ironwood Pharmaceuticals, Inc.'s (NASDAQ:IRWD) Earnings Simply Wall St.
Feb-03-21 04:01PM	Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2020 Investor Update Call Business Wire
Jan-05-21 07:30AM	Ironwood Pharmaceuticals to Present at the 39th Annual J.P. Morgan Healthcare Conference Business Wire
Dec-05-20 11:32AM	Ironwood (IRWD) Up 19.7% Since Last Earnings Report: Can It Continue? Zacks
Dec-04-20 08:44AM	JAZZ's Zepzelca Combo SCLC Study Fails, Drug Still Promising Zacks
Dec-03-20 08:30AM	Ironwood Pharmaceuticals Appoints Jay P. Shepard to Board of Directors Business Wire
Nov-30-20 01:39PM	FibroGen's (FGEN) Evrenzo Approved in Japan for Another Indication Zacks
Nov-27-20 12:20PM	Can Ironwood (IRWD) Run Higher on Rising Earnings Estimates? Zacks
08:57AM	Matinas BioPharma (MTNB) Looks Good: Stock Adds 8.6% in Session Zacks
08:36AM	5 High Earnings Yield Stocks to Add to Your Portfolio Zacks
Nov-07-20 12:31AM	Ironwood Pharmaceuticals Inc (IRWD) Q3 2020 Earnings Call Transcript Motley Fool
Nov-06-20 04:01PM	Ironwood Pharmaceuticals to Present at the 29th Annual Credit Suisse Healthcare Conference Business Wire +6.59%
10:00AM	Ironwood (IRWD) Q3 Earnings Beat on Solid Linzess Sales Zacks
09:43AM	Ironwood appoints Sarissa's Denner to board, shares surge Reuters
Nov-05-20 07:05PM	Ironwood Pharmaceuticals (IRWD) Tops Q3 Earnings and Revenue Estimates Zacks
04:03PM	Ironwood Pharmaceuticals Reports Strong Third Quarter 2020 Results and Increases Full Year 2020 Financial Guidance Business Wire
04:01PM	Ironwood Pharmaceuticals Appoints Alexander Denner, Ph.D., to Board of Directors Business Wire
02:30PM	Ironwood Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
09:23AM	Ironwood Pharmaceuticals, Inc.'s (NASDAQ:IRWD) Intrinsic Value Is Potentially 74% Above Its Share Price Simply Wall St.
Oct-29-20 12:35PM	Ironwood Pharmaceuticals (IRWD) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release Zacks
Oct-22-20 04:01PM	Ironwood Pharmaceuticals to Host Third Quarter 2020 Investor Update Call Business Wire
12:33PM	Ironwood Pharmaceuticals (IRWD) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release Zacks
Sep-30-20 11:08AM	Ironwood to End IW-3718 Development After Study Failure Zacks
Sep-29-20 08:55AM	Ironwood Sinks 11% After Gastro Disease Treatment Study Halt SmarterAnalyst
07:15AM	Ironwood to Discontinue IW-3718 Development Program Following Results from Planned Efficacy Assessment Business Wire
Sep-27-20 07:33AM	3 Great Stocks Under $10 Motley Fool
Sep-14-20 10:55PM	Hedge Funds Getting More Bullish On Ironwood Pharmaceuticals, Inc. (IRWD) Insider Monkey
Sep-05-20 11:31AM	Why Is Ironwood (IRWD) Down 3.1% Since Last Earnings Report? Zacks
Sep-02-20 04:00PM	Ironwood Pharmaceuticals to Participate in Upcoming September Investor Conferences Business Wire
Aug-26-20 12:20PM	Surging Earnings Estimates Signal Upside for Ironwood (IRWD) Stock Zacks
Aug-07-20 02:52PM	Ironwood Pharmaceuticals'(NASDAQ:IRWD) Share Price Is Down 32% Over The Past Three Years. Simply Wall St.
11:18AM	Ironwood (IRWD) Q2 Earnings Beat on Solid Linzess Sales Zacks
Aug-06-20 10:45AM	Ironwood Pharmaceuticals (IRWD) Beats Q2 Earnings and Revenue Estimates Zacks
07:00AM	Ironwood Pharmaceuticals Reports Second Quarter 2020 Results; Delivered GAAP Net Income of $25 Million and Adjusted EBITDA of $33 Million Business Wire
Jul-30-20 12:33PM	Ironwood Pharmaceuticals (IRWD) Reports Next Week: What You Should Expect Zacks
Jul-23-20 04:05PM	Ironwood Pharmaceuticals to Host Second Quarter 2020 Investor Update Call Business Wire
12:17PM	3 Growth Stocks May Present Value Opportunities GuruFocus.com
Jul-21-20 07:00AM	Ironwood Announces Updates Designed to Strengthen IW-3718 Phase III Program for Refractory Gastroesophageal Reflux Disease (GERD) Business Wire -6.98%
Jul-12-20 07:40PM	Did Hedge Funds Make The Right Call On Ironwood Pharmaceuticals, Inc. (IRWD) ? Insider Monkey
Jun-08-20 02:51AM	Hedge Funds Still Bullish On Ironwood Pharmaceuticals, Inc. (IRWD) Insider Monkey
Jun-05-20 11:31AM	Why Is Ironwood (IRWD) Down 3.6% Since Last Earnings Report? Zacks
Jun-03-20 09:56AM	Biotech Stock Roundup: GILD's Coronavirus Drug Update, NTLA-REGN Deal & More Zacks
09:04AM	Ironwood Pharmaceuticals (IRWD) Looks Good: Stock Adds 7.6% in Session Zacks
08:32AM	Edited Transcript of IRWD earnings conference call or presentation 6-May-20 8:30pm GMT Thomson Reuters StreetEvents
May-28-20 09:10AM	Ironwood to Halt MD-7246 Development After Study Failure Zacks -8.40%
May-27-20 08:51AM	AbbVie, Ironwood to discontinue experimental IBS drug MarketWatch -8.97%
08:00AM	Ironwood and AbbVie Report Top-line Phase II Data for MD-7246 in Patients with Abdominal Pain Associated with Irritable Bowel Syndrome with Diarrhea (IBS-D) Business Wire
May-11-20 06:53AM	H.C. Wainwright Sticks to Their Hold Rating for Ironwood Pharma Investing.com +5.59%
May-07-20 10:00PM	Ironwood Pharmaceuticals Inc (IRWD) Q1 2020 Earnings Call Transcript Motley Fool
10:56AM	Ironwood (IRWD) Misses Q1 Earnings and Revenue Estimates Zacks
May-06-20 07:15PM	Ironwood Pharmaceuticals (IRWD) Misses Q1 Earnings and Revenue Estimates Zacks
04:05PM	Ironwood Pharmaceuticals Reports First Quarter 2020 Results and Provides Update on Impact of COVID-19 Pandemic Business Wire
Apr-29-20 12:34PM	Ironwood Pharmaceuticals (IRWD) Reports Next Week: Wall Street Expects Earnings Growth Zacks
Apr-28-20 04:05PM	Ironwood and Allergan Receive Notices of Allowance for Patent Applications Covering 72 mcg Dose of LINZESS® (linaclotide) Business Wire
Apr-16-20 04:05PM	Ironwood Pharmaceuticals to Host First Quarter 2020 Investor Update Call Business Wire
12:10PM	Can Ironwood (IRWD) Keep the Earnings Surprise Streak Alive? Zacks
Apr-10-20 08:49AM	An Intrinsic Calculation For Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Suggests It's 35% Undervalued Simply Wall St.
Apr-07-20 03:32PM	Hedge Funds Have Never Been This Bullish On Ironwood Pharmaceuticals, Inc. (IRWD) Insider Monkey
Mar-26-20 09:00AM	Ironwood Pharmaceuticals Provides Update on Impact of COVID-19 Business Wire
Mar-14-20 11:30AM	Ironwood (IRWD) Down 22.1% Since Last Earnings Report: Can It Rebound? Zacks
Feb-26-20 04:05PM	Ironwood Pharmaceuticals Announces Publication of Positive IW-3718 Phase IIb Data in Gastroenterology Business Wire
Feb-25-20 04:05PM	Ironwood Pharmaceuticals to Present at Upcoming March Investor Conferences Business Wire
Feb-20-20 11:13AM	Edited Transcript of IRWD earnings conference call or presentation 13-Feb-20 1:30pm GMT Thomson Reuters StreetEvents
Feb-14-20 09:50AM	Ironwood (IRWD) Surpasses Q4 Earnings and Sales Estimates Zacks -7.73%
Feb-13-20 09:45AM	Ironwood Pharmaceuticals (IRWD) Q4 Earnings and Revenues Beat Estimates Zacks
08:48AM	Ironwood (IRWD) Beats Earnings & Revenues Estimates in Q4 Zacks
07:00AM	Ironwood Pharmaceuticals Reports Strong Fourth Quarter and Full Year 2019 Results, Exceeding Full Year 2019 Guidance; Provides Full Year 2020 Guidance Business Wire
Feb-10-20 12:38PM	Does The Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Share Price Tend To Follow The Market? Simply Wall St.
10:13AM	What's in Store for Ironwood (IRWD) This Earnings Season? Zacks
Feb-06-20 12:31PM	Ironwood Pharmaceuticals (IRWD) Earnings Expected to Grow: Should You Buy? Zacks
Jan-30-20 04:05PM	Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2019 Investor Update Call Business Wire
Jan-22-20 09:20AM	Ironwood and Allergan Announce Settlement with Teva Resolving LINZESS® (linaclotide) Patent Litigation Business Wire
Jan-06-20 08:00AM	Ironwood and Allergan Announce Settlement Resolving LINZESS® (linaclotide) Patent Litigation Business Wire +6.30%
Jan-02-20 04:01PM	Ironwood Pharmaceuticals to Present at J.P. Morgan Healthcare Conference Business Wire
09:35AM	5 Reasons Why Ironwood Stock Should Be in Your Portfolio Zacks
Dec-31-19 08:58AM	MEI Pharma (MEIP) Catches Eye: Stock Jumps 8.1% Zacks
Dec-27-19 12:00PM	Are You Looking for a Top Momentum Pick? Why Ironwood Pharmaceuticals (IRWD) is a Great Choice Zacks
Dec-26-19 09:00AM	Marinus Pharmaceuticals (MRNS) Catches Eye: Stock Jumps 7.7% Zacks
Dec-25-19 11:30AM	Is Ironwood Pharmaceuticals (IRWD) Outperforming Other Medical Stocks This Year? Zacks
Dec-23-19 08:33AM	Moving Average Crossover Alert: Ironwood Pharmaceuticals Zacks
Dec-19-19 07:34PM	Heres What Hedge Funds Think About Ironwood Pharmaceuticals, Inc. (IRWD) Insider Monkey
Dec-18-19 09:23AM	Pacira's Late-Stage Study on Exparel Label Expansion Positive Zacks
Dec-13-19 08:39AM	Assertio to Divest Shingles Pain Drug to Alvogen for $127.5M Zacks
Dec-10-19 09:15AM	Some Ironwood Pharmaceuticals (NASDAQ:IRWD) Shareholders Are Down 21% Simply Wall St.
08:33AM	Turning Point (TPTX) Catches Eye: Stock Jumps 6.1% Zacks
Dec-09-19 10:20AM	Sage Therapeutics (SAGE) in Focus: Stock Moves 7.1% Higher Zacks
Dec-03-19 08:51AM	Top Ranked Momentum Stocks to Buy for December 3rd Zacks
Nov-29-19 09:39AM	Catalyst Focuses on Firdapse Label Expansion Amid Competition Zacks

Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZESS name in the United States and Mexico, as well as under the CONSTELLA name in the Canada and European Union. The company is also developing IW-3300, a GC-C agonist, which is in pre-clinical development for the treatment of visceral pain conditions, including interstitial cystitis/bladder pain syndrome and endometriosis. It has strategic partnerships with AbbVie Inc., AstraZeneca AB, and Astellas Pharma Inc. for the development and commercialization of linaclotide. The company was formerly known as Microbia, Inc. and changed its name to Ironwood Pharmaceuticals, Inc. in April 2008. Ironwood Pharmaceuticals, Inc. was incorporated in 1998 and is headquartered in Boston, Massachusetts.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
DENNER ALEXANDER J	Director	Mar 10	Buy	10.54	75,000	790,500	16,390,000	Mar 10 07:06 PM
DENNER ALEXANDER J	Director	Mar 08	Buy	10.30	150,000	1,545,000	16,315,000	Mar 10 07:06 PM
DENNER ALEXANDER J	Director	Mar 05	Buy	10.01	175,000	1,751,750	16,165,000	Mar 05 07:19 PM
DENNER ALEXANDER J	Director	Mar 04	Buy	10.00	250,000	2,500,000	15,990,000	Mar 05 07:19 PM
DENNER ALEXANDER J	Director	Mar 03	Buy	10.02	350,000	3,507,000	15,740,000	Mar 05 07:19 PM
DENNER ALEXANDER J	Director	Mar 02	Buy	9.56	500,000	4,780,000	15,390,000	Mar 02 08:18 PM
DENNER ALEXANDER J	Director	Mar 01	Buy	9.60	344,900	3,311,040	14,890,000	Mar 02 08:18 PM
DENNER ALEXANDER J	Director	Feb 26	Buy	9.20	505,100	4,646,920	14,545,100	Mar 02 08:18 PM
Owens Edward P	Director	Feb 26	Buy	8.90	3,000	26,700	218,954	Mar 02 04:41 PM
MCCOURT Thomas A	President	Feb 26	Sale	9.11	14,685	133,780	471,577	Mar 02 04:40 PM
Mallon Mark	Chief Executive Officer	Feb 26	Sale	9.11	30,675	279,449	470,605	Mar 02 04:37 PM
Kilroy Conor	SVP, GC & Secretary	Feb 26	Sale	9.11	6,989	63,670	122,336	Mar 02 04:36 PM
Consylman Gina	SVP, CFO & Treasurer	Feb 26	Sale	9.11	18,406	167,679	336,244	Mar 02 04:34 PM
Shetzline Michael	CMO, SVP & Head of Drug Devt.	Feb 26	Sale	9.11	4,439	40,439	160,859	Mar 02 04:44 PM
Rickard Jason	SVP, Chief Operating Officer	Feb 26	Sale	9.11	13,651	124,361	306,682	Mar 02 04:43 PM
Owens Edward P	Director	Feb 25	Buy	9.11	5,000	45,550	215,954	Feb 26 05:15 PM
Owens Edward P	Director	Feb 24	Buy	9.26	7,000	64,820	210,954	Feb 26 05:15 PM
MCCOURT Thomas A	President	Dec 14	Option Exercise	9.89	99,988	988,881	421,720	Dec 16 04:49 PM
MacDonald Kelly	Chief Accounting Officer	Dec 04	Option Exercise	9.12	5,639	51,428	98,680	Dec 08 04:01 PM
MacDonald Kelly	Chief Accounting Officer	Dec 04	Sale	12.50	5,639	70,488	93,041	Dec 08 04:01 PM
MacDonald Kelly	Chief Accounting Officer	Nov 11	Option Exercise	9.31	3,561	33,153	96,602	Nov 13 04:02 PM
MacDonald Kelly	Chief Accounting Officer	Nov 11	Sale	11.75	3,561	41,842	93,041	Nov 13 04:02 PM
Kilroy Conor	SVP, GC & Secretary	Nov 09	Sale	10.92	836	9,129	128,833	Nov 10 04:09 PM
Consylman Gina	SVP, CFO & Treasurer	Nov 09	Sale	10.92	1,415	15,452	269,699	Nov 10 04:03 PM
Rickard Jason	SVP, Chief Operating Officer	Nov 09	Sale	10.92	394	4,302	235,382	Nov 10 04:12 PM
MacDonald Kelly	Chief Accounting Officer	Nov 09	Sale	10.92	925	10,101	93,041	Nov 10 04:10 PM
MacDonald Kelly	Chief Accounting Officer	Nov 06	Sale	11.25	1,872	21,060	93,966	Nov 10 04:10 PM
MacDonald Kelly	Chief Accounting Officer	Oct 08	Sale	10.50	22,714	238,497	95,838	Oct 13 04:03 PM
McHugh Julie	Director	Sep 08	Sale	9.77	7,950	77,672	123,107	Sep 09 06:26 PM
Rickard Jason	SVP, Chief Operating Officer	Aug 17	Sale	10.14	689	6,986	235,776	Aug 19 04:05 PM
MacDonald Kelly	Chief Accounting Officer	Aug 17	Sale	10.14	575	5,830	118,552	Aug 19 04:01 PM
OLANOFF LAWRENCE S	Director	Jun 10	Sale	10.06	11,350	114,181	68,629	Jun 12 04:32 PM
Rickard Jason	SVP, Chief Operating Officer	May 11	Sale	10.35	510	5,278	234,580	May 13 05:23 PM
MCCOURT Thomas A	President	May 11	Sale	10.35	1,697	17,564	319,847	May 13 05:22 PM
MacDonald Kelly	Chief Accounting Officer	May 11	Sale	10.35	1,153	11,934	118,147	May 13 05:20 PM
Mallon Mark	Chief Executive Officer	May 11	Sale	10.35	23,206	240,182	501,280	May 13 05:21 PM
Kilroy Conor	SVP, GC & Secretary	May 11	Sale	10.35	716	7,411	128,921	May 13 05:19 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience